rFVIII

BIOLOGICAL2 trials

Sponsors

Craig Seaman, Baxalta now part of Shire

Conditions

HemophiliaVon Willebrand Disease (VWD)

Phase 2

Weight-based Dosing in Hemophilia A

TerminatedNCT02586012

Craig SeamanHemophilia

Start: 2015-09-30End: 2020-01-10Updated: 2020-09-25

Phase 3

A Study of Recombinant Von Willebrand Factor (rVWF) in Pediatric and Adult Participants With Severe Von Willebrand Disease (VWD)

CompletedNCT03879135

Baxalta now part of ShireVon Willebrand Disease (VWD)

Start: 2019-04-01End: 2025-01-30Updated: 2025-09-03

Related Papers

Recombinant von willebrand factor for perioperative management of bleeding in pediatric patients with severe von willebrand disease: Interim results from a phase 3 multicenter study and a phase 3b continuation study

Blood2025-11-03

Recombinant von Willebrand factor prophylaxis in patients with severe von Willebrand disease: phase 3 study results

Blood2022-04-1932 citations